Takhzyro (Lanadelumab)

Medical Uses: Takhzyro contains the drug lanadelumab-flyo, which is a biologic medication. It is a plasma kallikrein inhibitor (monoclonal antibody) used for prophylaxis to treat or prevent attacks of types I and II hereditary angioedema (HAE) in patients aged 12 years and older. 

It is not known if takhzyro injection is safe and effective in children aged under 12 years.

Recommended Dosage: Takhzyro; a preventive treatment you take just once every two weeks; comes as Injection: 300 mg/2 mL (150 mg/mL) solution, single-dose, ready-to-use, prefilled syringe.

The recommended dose is 300 mg every two weeks for patients starting on Takhzyro. If patients have zero attacks for more than six months, their health specialist may consider prescribing Takhzyro 300 mg every four weeks. It is not advisable to attempt to take this injection without first being trained by a health specialist.

• Hypersensitivity reactions may occur. In case of a severe hypersensitivity reaction, discontinue Lanadelumab-flyo administration and institute apt treatment.
• Takhzyro treatment may not be appropriate for you in case you have certain medical conditions or other factors that can affect your health. Talk with your health specialist about your health history prior to starting therapy with Takhzyro. 
• Patients may have injection site reactions to lanadelumab 300 mg. These are skin reactions that happen where doses of the medicine are injected.
• Lanadelumab-flyo has not been evaluated in pregnant or breastfeeding women. Discuss with your doctor about the risk of taking this injection if you are pregnant, want to be pregnant, are breastfeeding, or want to breastfeed.
• Takhzyro injection isn’t known to interact with alcohol. In case you’re concerned or have any question about drinking alcohol while on therapy with Takhzyro, talk with your health specialist.

What documents are required to import TAKHZYRO® to India?

TAKHZYRO® (Lanadelumab-flyo) Injection can be imported by patients or government hospitals in the name of the patients only.

The following documentation is required to import the product:

• Valid prescription from a qualified doctor.
• Patient’s diagnostic reports.
• Patient’s Identity Proof (issued by the government of India).

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• Valid prescription from the doctor.
• Import permit if applicable.

Is TAKHZYRO® available in India?

TAKHZYRO® (Lanadelumab Injection) is a prescription medication that legally requires a medical prescription to be dispensed.

Urgent Meds helps import prescription medicines on the named patient supply (NPS). Urgent Meds can facilitate:

• Availability of TAKHZYRO® in India (Delhi, Mumbai, Chennai, Hyderabad, Kolkata, Ahmedabad, Bangalore, Pune, and other cities).
• Medicine price.
• Finding a genuine and reliable source from the USA, Canada, Europe, and Australia.
• Ensuring 100% transparency.

TAKHZYRO® can be made available to patients, doctors, and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

Urgent Meds can facilitate the supply of TAKHZYRO® (prescription medicines) to all locations in the world and in India after fulfilling the legal requirements (if applicable).

Please contact +1-647-818-4196 or write to info@urgentmeds.in for TAKHZYRO® price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Urgent Meds is proficient in sourcing TAKHZYRO (Cancer Treatment Medicines) from around the world and has the capability to supply it. We offer global access to the best available treatment for our customers worldwide.

Urgent Meds is committed to dispensing any valid prescription promptly. All prescriptions are dispensed and verified by registered pharmacists and are dispatched only to the patient’s address from New Delhi, India. Your health and well-being are our top priorities.

What is the Generic Name for the trade name drug Takhzyro®?

Lanadelumab-flyo is the generic name for the trade name drug Takhzyro®.

What is the Manufacturer Name of Takhzyro®?

Takhzyro® is manufactured by Shire Pharmaceuticals.

Is Takhzyro® approved by the FDA?

Yes, Takhzyro® is approved by the FDA. Date of first/initial approval: August 23, 2018.

What is the dosage and form of Takhzyro® supplied?

Takhzyro® is supplied as an Injection: 300 mg/2 mL (150 mg/mL) solution in a single-dose vial for subcutaneous administration.

Where can I get Takhzyro® at the best price in India?

To get the best Takhzyro® price in India, contact Urgent Meds (WHO-GDP & ISO 9001:2008 authorized Company). A valid medical prescription is required while buying Takhzyro®.

What are the most common side effects with Takhzyro®?

The most common side effects with Takhzyro® include: rash, injection site reactions, upper respiratory infections, dizziness, headache, myalgia, and diarrhea.

How much does Takhzyro® cost in India?

The cost of Takhzyro® in India is reasonable and can vary. To procure this type I/II hereditary angioedema medicine authentically, you can Call/WhatsApp +1-647-818-4196 or send an email to info@urgentmeds.in.

What are the storage conditions of Takhzyro®?

Store vials refrigerated at 36-46°F (2-8°C). Do not freeze or shake. Keep the vials in the original carton to protect from light.

Will I need to use Takhzyro® 300 Injection long term?

If Takhzyro® 300 Injection works for you, your doctor will likely recommend long-term use of this medicine.

What if I miss a dose of Takhzyro® Injection?

If you miss a dose, consult your doctor. They will advise you on whether to take the missed dose as soon as you remember or to skip it and proceed with your next scheduled dose.

Is it safe to buy Takhzyro® online from India?

Yes, you can buy Takhzyro® online from India at the best price from Urgent Meds if Takhzyro® has not been approved or is not available in your country.